Testimonials

 

“The best molecular Dx meeting I have attended in several years” 
VP, Translational Oncology, Pfizer

“An excellent view of the landscape with well integrated content from pharma, dx, clinical research and agency perspectives. This has been one of the best commercial meetings I have attended in memory” 
Advanced Cell Diagnostics

 “One of the best meetings I’ve attended. Outstanding!”
Director, Merck

“The event has been very valuable. A great conference to be informed of importance and current issues related to CDx/MDx. I am very glad I chose to attend as it has been a wealth of information” 
Immunogen

“Outstanding meeting with first class speakers. I learned a lot and I will certainly recommend the meeting to my colleagues….”
Director, Oncology Business Opportunities, Sanofi 

 “This was my first conference I have attended by Hanson Wade - great job! The people made this conference extraordinary” 
PricewaterhouseCoopers

 “Excellent cross section of core science, regulatory, commercialization and project management from both pharma and diagnostic companies. Very educational”
Eli Lilly

“A very engaging integration of pharma and diagnostics perspectives. Exciting!”
VP, Millennium  

“An intimate session where Rx meets Dx and vice versa. Very informative in terms of Rx vs. Dx perspectives” 
Director, Dako 

“Successful in bringing together pharma and diagnostics for information sharing, discussion and networking. Very informative, good representation, great networking”
Abbott Molecular 

“Great breadth and depth with all stakeholders represented”
AstraZeneca 

"Good conference covering all aspects of companion diagnostics"
Head of Biomarkers, Transgene

"Good meeting. I particularly enjoyed the depth of the presentations and discussions"
Global Head of Strategy, Molecular Diagnostics, Novartis